Firm Secures Favorable Northwest Biotherapeutics Arbitration Outcome
Lane Powell has obtained a favorable arbitration outcome for its client Northwest Biotherapeutics. Northwest Biotherapeutics, a Seattle area company that is working on potential cures for certain types of cancer, prevailed in a three-day arbitration hearing in a fee dispute with its former investment banking firm. The investment banking firm sought substantial fees and stock warrants. The arbitrator agreed with Northwest Biotherapeutic’s argument that the investment banking firm was only entitled to $6,000 in fees. Firm shareholder Randall Beighle handled the case with the help of attorney William Krause.